BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 15079851)

  • 21. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial.
    Işeri E; Kiliç BG; Senol S; Karabacak NI
    Methods Find Exp Clin Pharmacol; 2007; 29(1):47-52. PubMed ID: 17344944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
    Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
    Heal DJ; Cheetham SC; Smith SL
    Neuropharmacology; 2009 Dec; 57(7-8):608-18. PubMed ID: 19761781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC; Nutt DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug dependence and methylphenidate].
    Sora I; Ikari M; Ikeda K
    Seishin Shinkeigaku Zasshi; 2008; 110(10):941-5. PubMed ID: 19278070
    [No Abstract]   [Full Text] [Related]  

  • 26. Treating problem children with stimulant drugs.
    Sroufe LA; Stewart MA
    N Engl J Med; 1973 Aug; 289(8):407-13. PubMed ID: 4146358
    [No Abstract]   [Full Text] [Related]  

  • 27. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Massive variation in Ritalin prescribing.
    Gainsbury S
    Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
    [No Abstract]   [Full Text] [Related]  

  • 29. The answerable question and a hierarchy of evidence.
    Hamilton J
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):596-600. PubMed ID: 15908843
    [No Abstract]   [Full Text] [Related]  

  • 30. The preschool ADHD Treatment Study (PATS) as the culmination of twenty years of clinical trials in pediatric psychopharmacology.
    March JS
    J Am Acad Child Adolesc Psychiatry; 2011 May; 50(5):427-30. PubMed ID: 21515189
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract]   [Full Text] [Related]  

  • 32. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 33. Methylphenidate (Ritalin) use and abuse.
    Crutchley A; Temlett JA
    S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
    [No Abstract]   [Full Text] [Related]  

  • 34. What exactly are the benefits of stimulants for ADHD?
    Advokat C
    J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
    [No Abstract]   [Full Text] [Related]  

  • 35. Explosive outbursts associated with methylphenidate.
    Adrian N
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):618-9. PubMed ID: 11392335
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate euphoria.
    Corrigall R; Ford T
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
    [No Abstract]   [Full Text] [Related]  

  • 38. [Paradoxical effect of methylphenidate in the treatment of a patient with severe traumatic brain injury].
    Grønborg P; Liljegren J; Jansen J
    Ugeskr Laeger; 2009 Jun; 171(26):2201-2. PubMed ID: 19671403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 40. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.